Uploads Contact
/
Login Upload

  • Search Results for 'Inhibitors Inhibitor'

Best Practices in Nursing Management of EGFR Inhibitor Rash
Best Practices in Nursing Management of EGFR Inhibitor Rash
olivia-moreira
Chapter 15
Chapter 15
cheryl-pisano
The direct oral anticoagulants (DOACs)
The direct oral anticoagulants (DOACs)
faustina-dinatale
Comparative effect of Various HDAC-inhibitors in-vitro on T
Comparative effect of Various HDAC-inhibitors in-vitro on T
pasty-toler
Myeloid Updates From the Summer Congresses
Myeloid Updates From the Summer Congresses
aaron
Enzyme
Enzyme
yoshiko-marsland
Updates for Dermatologists and Rheumatologists on PsA Management: Role of IL-17 Inhibitors
Updates for Dermatologists and Rheumatologists on PsA Management: Role of IL-17 Inhibitors
marina-yarberry
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
tatyana-admore
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
yoshiko-marsland
Chapter 66 Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
Chapter 66 Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
stefany-barnette
Chapter 66 Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
Chapter 66 Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
lindy-dunigan
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
ellena-manuel
Simulation of the Likelihood of Plant Growth
Simulation of the Likelihood of Plant Growth
giovanna-bartolotta
Pharmacological Management of Congestive Heart Failure
Pharmacological Management of Congestive Heart Failure
natalia-silvester
GraphSig
GraphSig
giovanna-bartolotta
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
marina-yarberry
Balancing risk factors for inhibitors development in clinic
Balancing risk factors for inhibitors development in clinic
phoebe-click
Resistance to Direct Acting Antiviral Therapy
Resistance to Direct Acting Antiviral Therapy
tawny-fly
Recent Developments in AIDS Diagnosis & Treatment
Recent Developments in AIDS Diagnosis & Treatment
myesha-ticknor
Medications Used in the Treatment of Diabetes Mellitus
Medications Used in the Treatment of Diabetes Mellitus
sherrill-nordquist
Antifungal agents
Antifungal agents
celsa-spraggs
Enablers and Inhibitors for Expediting Systems and Software
Enablers and Inhibitors for Expediting Systems and Software
olivia-moreira
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
conchita-marotz
Combining inhibitor tolerance and D-Xylose fermentation in industrial Saccharomyces
Combining inhibitor tolerance and D-Xylose fermentation in industrial Saccharomyces
debby-jeon